Cano Health, Inc. CANOQ

0.24 0.00 0.00% as of 28 Jun
Market cap
$6.6M
P/E
0.0×
Growth Flags show if company had growth for consecutive years

Insider Decisions

in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 65.84%

Capital & Financial Ratios

Market Cap 6.62
Revenue 2,955.27
Net Income (1,516.52)
Free Cash Flow (163.37)
Net Debt (173.55)
Current Ratio 0.96
Debt/Equity (0.01)
P/E ratio 0.00
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth 75.48%
Next Y EPS Growth (76.26%)
Next 5Y EPS Growth —
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities

2021 2022 2023 Q'24
Cash 163 27 94 179
Receivables 133 234 76 54
Inventory 1 — — —
Other — — — —
317 341 183 255
2021 2022 2023 Q'24
Payables 81 106 108 60
ST’ Debt 17 46 48 —
Other 40 24 76 7
161 208 1,415 267
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — — 55.68%
Cash Flow — — 0.00%
Earnings — — 0.00%
Book Value — — 0.00%

Revenue

Mar Jun Sep Dec Year
’26 684 — — — —
’23 867 767 788 716 3,138
’22 704 689 665 680 2,739
’21 275 344 499 492 1,609
’20 — 171 263 397 832
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (49) — — — —
’23 (29) (15) (40) (44) (129)
’22 (37) (45) (2) (62) (146)
’21 (15) (43) (36) (24) (118)
’20 — (13) (8) 12 (9)
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 (50) — — — —
’23 (35) (22) (47) (45) (148)
’22 (45) (58) (21) (73) (196)
’21 (17) (48) (52) (35) (152)
’20 — (17) (13) 9 (21)
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 (91.10) — — — —
’23 (12.00) (51.00) (91.87) (5.85) (242.60)
’22 0.00 (3.00) (23.00) (61.00) (95.00)
’21 (0.21) (7.00) (9.00) (12.00) (28.00)
’20 (0.02) 0.00 0.00 (0.33) (102.99)
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

4
1Buy 2 3Hold 4 5Sell
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
— — — — — — 500.00 787.00 98.01 5.13

Analyst estimates 2024–2026

Powerpack
Low Price
— — — — — — 1,470.00 1,743.00 975.00 190.00
High Price
— — — — — — — — 4,365 2,700
Employees
— — — — — 0 0 0 1 1
Revenue/Emp
— — — — — 361 832 1,609 2,739 3,138
Revenue
— — — — — 100.00% 100.00% 100.00% 100.00% 100.00%
Gross Margin
— — — — — (20) (70) (117) (426) (1,101)
EBT
— — — — — (5.47%) (8.47%) (7.25%) (15.56%) (35.08%)
EBT Margin
— — — 0 — (20) (71) (117) (428) (1,099)
Net Income
— — — — — 7 25 54 417 635
Depreciation
— — — — — 0.00 0.00 943.86 1,249.68 1,139.30
Revenue/Sh
— — — — — (0.01) (4.12) (11.00) (95.00) (111.30)
Earnings/Sh
— — — — — 0.00 0.00 (69.22) (66.77) (46.86)
Cash Flow/Sh
— — — — — 0.00 0.00 (20.15) (22.60) (6.98)
Capex/Sh
— — — — — 0.00 0.00 (89.37) (89.37) (53.84)
Free CF/Sh
— — — — — 0.00 0.00 468.34 225.52 (194.26)
Book Value/Sh
— — — — — 0 0 2 2 3
Shares
— — — — — 0.00 0.00 0.00 0.00 0.00
PE Ratio
— — — — — 0.00 0.00 0.94 0.09 0.00
PS Ratio
— — — — — 0.00 2,330.71 1.90 0.50 0.00
PB Ratio
— — — — — 0.00 0.00 1.42 0.47 (0.01)
EV/Sales
— — — — — 0.00 (5,450.15) (15.03) (6.54) 0.16
EV/FCF
— — — — — (15) (9) (118) (146) (129)
Op' Cash Flow
— — — — — (9) (12) (34) (50) (19)
Capex
— — — — — (25) (21) (152) (196) (148)
FCF
— — — — — 0 44 156 132 (1,233)
Working Cap'
— — — — — — 499 935 1,063 55
Total Debt
— — — — — — 465 772 1,036 (39)
Net Debt
— — — — — 0 50 799 494 (535)
Sh' Equity
— — — — — (86,754.39%) (23.14%) (1.31%) (10.18%) (40.40%)
ROA
— — — — — 0.00% (0.03%) (5.38%) (17.84%) 0.00%
ROIC
— — — — — (79.12%) (286.43%) (4.25%) (32.06%) 2,919.11%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2023 · latest quarter Mar 2024

Cano Health, Inc. (CANOQ) key facts

  • Cano Health, Inc. (CANOQ) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
  • Cano Health, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $3.1 billion, up 14.6% from fiscal 2022.
  • As of June 28, 2024, CANOQ traded at $0.24, a market capitalization of $6.6 million.
  • Return on equity was 2,919.1% and debt-to-equity -0.01.

Source: company filings (standardised) and stockrow calculations.

Cano Health, Inc. (CANOQ) Latest News

News by impact score

Fine-tune

17 May

4

Cano Health Inc. wins creditor support to cut $1 billion in debt and exit bankruptcy under new owners. The significant debt reduction and ownership change are expected to have a major impact on Cano Health, Inc.'s future and market performance.

stockrow.com/CANOQ · Data as of Mar 31, 2024 · For information only; not investment advice. · © 2026 stockrow.com